Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 22, 2022
<sup>177</sup>Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
Amir Karimzadeh, Matthias Heck, Robert Tauber, et al.
EJNMMI Research
|
February 3, 2026
Estimation of split renal function using [<sup>18</sup>F]-flotufolastat PET/CT compared with [<sup>68</sup>Ga]-PSMA-11 and [<sup>99m</sup>Tc]-MAG3 scintigraphy
Michael Christian Marius Gammel, Charlotte Olufs, Kimberley Hansen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancer
Thomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 21, 2026
Value of a repeat <sup>18</sup>F-flotufolastat PET scan following a negative scan in patients with suspected biochemical recurrence of prostate cancer after radical prostatectomy
Sonja Kirchhoff, Andreas Lederer, Theo Lorenzini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer
Andrei Gafita, Isabel Rauscher, Margitta Retz, et al.
World Journal of Urology
|
June 24, 2015
Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome
Georgios Hatzichristodoulou, Stefan Wagenpfeil, Gregor Weirich, et al.
Urologic Oncology
|
October 11, 2011
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses
Tobias Maurer, Christos Pournaras, Juan A Aguilar-Pimentel, et al.
Minerva Urology and Nephrology
|
December 21, 2023
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer
Francesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy
Amir Karimzadeh, Matthias Heck, Robert Tauber, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
October 31, 2012
Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications
Robert Tauber, Sebastian Schmid, Thomas Horn, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 22, 2022
<sup>177</sup>Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
Amir Karimzadeh, Matthias Heck, Robert Tauber, et al.
EJNMMI Research
|
February 3, 2026
Estimation of split renal function using [<sup>18</sup>F]-flotufolastat PET/CT compared with [<sup>68</sup>Ga]-PSMA-11 and [<sup>99m</sup>Tc]-MAG3 scintigraphy
Michael Christian Marius Gammel, Charlotte Olufs, Kimberley Hansen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancer
Thomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 21, 2026
Value of a repeat <sup>18</sup>F-flotufolastat PET scan following a negative scan in patients with suspected biochemical recurrence of prostate cancer after radical prostatectomy
Sonja Kirchhoff, Andreas Lederer, Theo Lorenzini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer
Andrei Gafita, Isabel Rauscher, Margitta Retz, et al.
World Journal of Urology
|
June 24, 2015
Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome
Georgios Hatzichristodoulou, Stefan Wagenpfeil, Gregor Weirich, et al.
Urologic Oncology
|
October 11, 2011
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses
Tobias Maurer, Christos Pournaras, Juan A Aguilar-Pimentel, et al.
Minerva Urology and Nephrology
|
December 21, 2023
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer
Francesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy
Amir Karimzadeh, Matthias Heck, Robert Tauber, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
October 31, 2012
Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications
Robert Tauber, Sebastian Schmid, Thomas Horn, et al.
Page
of 4